Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortization of GoodwillAmortization of GoodwillAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)DivestmentsDividends Paid - CommonDividends Paid - CommonFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationAmortization - GoodwillCost of RevenueDepreciation & Amortization (IS)EBIATGross ProfitLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares OutstandingShares OutstandingShort-Term Debt repayments
Ratios

Enhabit (EHAB) Long-Term Debt Issuances (2022 - 2026)

Enhabit recorded quarterly Long-Term Debt Issuances of $315.0 million in Q1 2026, up 250.0% quarter-over-quarter from -$210.0 million in Q4 2022.

Enhabit's Long-Term Debt Issuances history runs 2 years deep, the most recent figure standing at $315.0 million for Q1 2026.

  • In Q1 2026, Long-Term Debt Issuances changed N/A year-over-year to $315.0 million; the TTM figure through Mar 2026 stood at $315.0 million (up 250.0% YoY), while the FY2022 annual figure was $190.0 million, changed N/A from the prior year.
  • Long-Term Debt Issuances came in at $315.0 million for Q1 2026 at Enhabit, up from -$210.0 million in the prior quarter.
  • In the past five years, Long-Term Debt Issuances ranged from a high of $315.0 million in Q1 2026 to a low of -$210.0 million in Q4 2022.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Long-Term Debt Issuances (Qtr)
1 HCA Healthcare 84.64 Bn 87.02 Bn 16.26 Bn -
2 Tenet Healthcare 15.22 Bn 14.39 Bn 4.41 Bn 14.00 Mn
3 Davita 13.10 Bn 13.96 Bn 1.07 Bn 1.26 Bn
4 Encompass Health 10.50 Bn 11.12 Bn 1.34 Bn 250.00 Mn
5 Ensign 9.69 Bn 9.09 Bn 293.37 Mn -
6 Universal Health Services 8.92 Bn 8.88 Bn 3.21 Bn -
7 Fresenius Medical Care AG 7.31 Bn 4.93 Bn 22,843.10 Bn 582.91 Mn
8 Chemed 5.83 Bn 5.81 Bn 215.76 Mn 135.48 Mn
9 Pacs 5.76 Bn 5.51 Bn 345.96 Mn -
10 Enhabit 706.56 Mn 680.46 Mn 130.60 Mn 315.00 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 315.00 Mn
Mar 31, 2026 315.00 Mn
Dec 31, 2022 -210.00 Mn
Dec 31, 2022 -210.00 Mn
Jun 30, 2022 170.00 Mn
Jun 30, 2022 170.00 Mn